Bridging the gap between patients and researchers
Sanguine has raised $6.0M in total funding. The most recent round was Debt Financing. The last funding was announced in October 2023.
Sanguine's investors include National Science Foundation, Catalio Capital Management, Mayo Clinic, FundersClub, BroadOak Capital Partners.
Sanguine is headquartered in Woburn, United States.
Bridging the gap between patients and researchers
Sanguine is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sanguine — Funding & Investors." VCBacked, October 31, 2023, https://www.vcbacked.co/company/sanguine. Accessed November 14, 2026.
VCBacked. (2023). Sanguine — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/sanguine
{{cite web |title=Sanguine — Funding & Investors |url=https://www.vcbacked.co/company/sanguine |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Sanguine? Request a listing update